Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2004-04-15 / Clin. Cancer Res. 2004 Apr;10(8):2645-51Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2004-04-07 / Am. J. Respir. Crit. Care Med. 2004 Jun;169(12):1322-30The role of idiotype vaccines in the treatment of human B-cell malignancies
/in International Publications, Malignant Lymphoma /von 2004-04-01 / Expert Rev Vaccines 2004 Apr;3(2):163-70[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)]
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2004-04-01 / Pneumologie 2004 Apr;58(4):210-6Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
/in Hyperthermia, International Publications, Ovarian Cancer /von 2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-91MTH-68/H oncolytic viral treatment in human high-grade gliomas
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2004-03-01 / J. Neurooncol. 2004 Mar-Apr;67(1-2):83-93Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-70Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response
/in International Publications, Micronutrients /von 2004-03-01 / 2004 Mar;41(Pt 2):138-41Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus
/in International Publications, Newcastle Disease Virus /von 2004-03-01 / Int. J. Oncol. 2004 Mar;24(3):623-34
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de